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Oxygenation response to NO in newborns with 
se ve re p ulm o nary hyper t e n s i o n 
Sir, 
We read with interest the article by Turbow et al .  in 
which a sub-group of infants (6 out of 13) with severe 
persi s t e n t p u lin on ar  y hypertension of the new born 
(PPHN) presented an improvement in oxygenation 
beyond a 30 min exposure period to inhaled nitric 
oxide (NO). They suggested that the clinical challenge 
was to identify these infants, since the response time to 
NO inhalation is multifactorial and dependent on the 
disease process associated with PPHN (1). 
Our protocol includes the evaluation of the response to 
NO at 6 h of therapy before considering other alterna- 
tive treatments such as extracorporeal membrane oxy- 
genation (ECMO). In  16 consecutive neonates (median 
gestational age 38 weeks, range 27-41; median birth- 
weight 2530g, range 550--4100) with PPHN, N O  (mean 
12.3 parts per million, range 5-40) caused an overall 
significant decrease in mean oxygenation index (OI), 
f r o m 7 4 ( r a n g e 2 7 ~ - 1 3 l ) t o 4 2 ( l l - l 2 7 ) ; p  < 0.04. How- 
ever, the oxygenation improvement markedly varied in 
relation to the underlying disease associated with 
PPHN: in the group of patients with asphyxia or 
sepsis (n.6) mean 01 significantly decreased, from 87 
(40-131) to 16 ( I  1-35) ( p  < 0.03); 0 1  moderately 
improved in premature patients with hyaline membrane 
disease ( / I  = 6), from 56 (27-72) to 40 (16-80) 
( p = NS); however, in newborn infants with pulmonary 
hypoplasia (congenital diaphragmatic hernia, n = 3, 
and oligohydramnios, n = 1 )  0 1  worsened from 83 
(72-91) to 100 (62-127) and this group of patients 
also showed no response to NO inhalation 30min 
after onset of therapy, three of them undergoing 
ECMO. 
Since N O  enhances oxygenation by a selective 
pulmonary vasodilation (2) and an improvement in 
ventilntion-perfusion matching (3 ) ,  we suggest that 
alveolar diseases, with collapsed and non-ventilated 
regions may limit inhaled NO to reach blood vessels in 
thcse terminal lung units, thus blunting its potential 
eflect, whereas a scarce response to N O  treatment in 
patients with severe bilateral hypoplastic lungs could be 
related to an early arrest in the development o f  their 
peripheral vascular and bronchial tree, associated with 
surfactant deficiency (4, 5) .  
In agreement with Turbow et al. we believe that some 
infants may benefit from a trial of NO therapy that 
exceeds 30 min since the response to NO treatment is 
multifactorial and dependent on the disease process. 
Nevertheless, infants with pulmonary hypoplasia 
could represent a distinct clinical sub-group of non- 
responders, early identifiable after onset of NO inhala- 
tion. In fact, in our series of early non-responders, 2 
RDS infants out of 3 showed an 01 improvement 6 h  
later, while the remaining 4 patients with PPHN 
secondary to hypoplastic lung persisted hypoxic. 
The exact reasons for this lack of acute response are 
still controversial. However, our data suggest that the 
absence of an acute N O  response in this specific struc- 
tural pulmonary disease may be an early predictor of 
poor outcome, prompting alternative treatments. 
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